SCHEMBL8263158

SCHEMBL8263158

CC(C)Oc1ccc2c(c1)CNC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.46
ITGA2B P08514 2/20 0.46
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.40
PARP10 Q53GL7 2/20 0.39
BRD4 O60885 1/20 0.39
BRPF1 P55201 1/20 0.39
ALDH1A3 P47895 1/20 0.37
POLB P06746 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
HTR6 P50406 1/20 0.36
GLA P06280 1/20 0.36
KCNH2 Q12809 1/20 0.36
RYR2 Q92736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3875484 0.98 ITGB3 (0.46) ITGB3ITGA2BALDH1A1KMT2APARP10
SCHEMBL8234177 0.86 PNMT (0.51) ITGB3ITGA2B
SCHEMBL17583864 0.86 ASIC3 (0.50) ITGB3ITGA2B
Tert-Butyl Formate SCHEMBL27721635 0.85 ITGB3 (0.41) ITGB3ITGA2BALDH1A1KMT2APARP10
Hydrochloric Acid SCHEMBL1266520 0.84 ITGB3 (0.51) ITGB3ITGA2B
SCHEMBL8263140 0.81 CHRNB2 (0.47) ITGB3ITGA2BALDH1A1KMT2APOLB
Hydrochloric Acid SCHEMBL31084083 0.79 CHRNB2 (0.46) ITGB3ITGA2BALDH1A1KMT2APOLB
SCHEMBL4563610 0.79 ITGB3 (0.42) ITGB3ITGA2BALDH1A1KMT2AKCNH2
SCHEMBL21762585 0.78 HRH3 (0.54) ITGB3ITGA2BHTR6
SCHEMBL10798207 0.78 ACHE (0.47) ALDH1A1KMT2APOLBGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188139-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-8188139-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
EP-1848694-B1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 HOFFMANN LA ROCHE (CH) 2009-11-25 EP disclosed
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES JOLIDON SYNESE 2009-08-13 US disclosed
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES JOLIDON SYNESE 2009-08-13 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
WO-2006082001-A1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 F.HOFFMANN-LA ROCHE AG (CH) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES CYP2B6, CYP2D6, CYP1A2 ITGB3 3451/4885ITGA2B 3236/4885ALDH1A1 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.